Tilray Brands (TLRY) Gross Profit Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 5.06% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 2.59% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -18.38% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -7.66% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -0.34% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 42.12% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 14.77% |
| 10 | Tilray Brands | 454.65 Mn | 394.45 Mn | 54.95 Mn | 5.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 5.66% |
| Nov 30, 2025 | -6.08% |
| Aug 31, 2025 | -3.75% |
| May 31, 2025 | -17.87% |
| Feb 28, 2025 | 5.29% |
| Nov 30, 2024 | 29.13% |
| Aug 31, 2024 | 35.09% |
| May 31, 2024 | 22.61% |
| Feb 29, 2024 | 522.22% |
| Nov 30, 2023 | 10.56% |
| Aug 31, 2023 | -9.09% |
| May 31, 2023 | 1,097.52% |
| Feb 28, 2023 | -129.37% |
| Nov 30, 2022 | 30.87% |
| Aug 31, 2022 | -4.59% |
| May 31, 2022 | -129.93% |
| Feb 28, 2022 | 30.78% |
| Nov 30, 2021 | -7.13% |
| Aug 31, 2021 | 45.81% |
| May 31, 2021 | -19.09% |